Dialysis Market - By Type, By Product and Services, By End Use - Global Forecast, 2025 - 2034

Dialysis Market Size

The global dialysis market was valued at USD 96.4 billion in 2024 and is expected to exhibit growth at a CAGR of 5.8% from 2025 to 2034. The high market growth is owing to advanced dialysis technology, rising spending on healthcare, growing number of elderly population, and improved healthcare policies from both governments and private organizations, among other contributing factors.
 

The increasing number of chronic kidney disease (CKD) cases owing to the rise in diabetes, high blood pressure, and an aging population is also a significant driver for this market. For instance, the Centers for Disease Control and Prevention (CDC) reports that, about 37 million adults aged 18 and older in the U.S. were living with CKD in 2021. Most of the patients with CKD also had diabetes and high blood pressure. When these patients' kidneys begin to fail, many choose dialysis treatment, which increases the need for dialysis services and equipment.
 

Furthermore, advancements in dialysis technology, such as more effective and simpler dialysis machines, wearable dialysis units, and even dialysis performed at home are enhancing the results for patients. These improvements also make the process more appealing for patients to undergo dialysis treatment.
 

Dialysis is a treatment that extensively purifies and filters the blood by using a machine. This treatment helps to keep electrolytes and fluids in balance when kidneys are dysfunctional. The two main types of dialysis are hemodialysis and peritoneal dialysis.
 

Dialysis Market Trends

The dialysis industry is witnessing significant growth driven by continuous innovations in technology, growing shift toward home dialysis, surging need for artificial intelligence in healthcare and data analytics, and expanding regulatory support, among other factors, are boosting the industry growth.
 

• Moreover, the trend toward home-based dialysis is increasing, which includes both peritoneal and home hemodialysis, and is expected to grow further as patients seek more independence in managing their treatment. Patients can now manage their care without the stress of frequent trips to a healthcare center. In addition, portable dialysis machines have rendered treatment at home safer and more effective. Additionally, the reimbursement policies adopted in economically developed countries have contributed to the acceptance of home dialysis.
   
• Providers of dialysis are changing their focus toward the needs of the patients and their overall health-related quality of life. New technologies that reduce the use of needles during dialysis and provide more silent machines result in less discomfort and worry about the patient. Moreover, the introduction of more flexible seating positions for the clinicians for performing the procedures and the use of dialysis chairs for the patients increases the comfort for patients and improve working conditions for caregivers. This is in line with the larger trend of personalized medicine where there is increasing value placed on satisfaction.
   
• Furthermore, policymakers and regulatory bodies are crafting reimbursement structures for home-based dialysis services, which is already in place in some regions and via Medicare in the U.S. It is likely that these initiatives will make dialysis treatment less costly and easier to obtain for patients. Additionally, the regulatory bodies are aiding the emergence of the market by facilitating the entry of new technologies. This assistance increases the utilization rate and reduces the costs incurred by patients and the healthcare system.
   

Dialysis Market Analysis

Based on type, the market is classified into hemodialysis, and peritoneal dialysis. The hemodialysis segment generated the highest revenue of USD 83.2 billion in 2024.
 

• Growing numbers of individuals experiencing chronic kidney disease (CKD) and end-stage renal disease (ESRD) are straining the capacity to provide hemodialysis services. As per the National Institute of Diabetes and Digestive and Kidney Diseases, over 786,000 Americans had ESRD in 2022, of which roughly 71% of them required hemodialysis to survive. Similarly, the International Diabetes Federation reports that in 2024, around 783 million people aged 20 to 79 had diabetes, hinting at an increased global ESRD prevalence and its associated requirements. As the incidence of chronic diseases increases, the growing demand for hemodialysis is expected to take an upward trajectory across the globe.
   
• showing a possible increase in global ESRD cases and hemodialysis needs. As chronic diseases become more common, the demand for hemodialysis is expected to grow across the world.
   
• Better hemodialysis machines have surfaced these days, and their ergonomic design makes them safer and easier to use. New devices and procedures like Dialyzer HDF, telemonitoring systems, and biocompatible dialyzers are increasing the comfort of treatments and the overall outcomes for patients. Such changes are geared toward facilitating the treatment process and are likely to result in increased compliance with hemodialysis protocols by both patients and healthcare practitioners.
   
• Nowadays, people are becoming more aware of kidney diseases, which, in turn, is helping doctors pinpoint issues at an earlier stage due to improved testing and screening techniques. This allows patients to initiate treatment for renal failure through hemodialysis at an early stage, which explains why there is an increase in the number of patients seeking hemodialysis treatment.
   
• There is also an increasing number of dialysis centers in regions that did not have any previously, such as the Asia Pacific, the Middle East, and even Latin America, and this is all thanks to government initiatives and funds from private businesses. With the opening of new centers, more people will be able to receive the kidney treatment they need, thereby expanding the entire industry.
   

Based on product and services, the dialysis market is classified into services, consumables, and equipment. The services segment accounted for USD 75.8 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 5.7% between the 2025 to 2034 period.
 

• The service segment includes chronic dialysis and acute dialysis. The chronic dialysis category is expected to dominant the segmental market during the forecast period. Patients undergoing chronic dialysis require consistent treatment, most commonly ranging from three to four sessions of hemodialysis in a week, or daily rounds of peritoneal dialysis. This treatment flexibility means that these patients will require chronic dialysis services, ensuring a positive shift in longitudinal demand.
   
• Furthermore, the integration of chronic dialysis services with new technologies such as biocompatible dialyzers, high-definition hemodialysis machines, and chronic dialysis at-home services has improved the quality and coverage of chronic dialysis services. These extensions not only improve patient results but also increase the number of patients willing to receive chronic dialysis.
   
• In addition, the improved understanding of CKD, paired with better and more precise tools that aid in diagnosis, has propelled treatment management. Patients affected by CKD are more receptive towards tackling the disease at an earlier stage and are more willing to adapt to chronic dialysis services for extended treatment, which stimulates growth within the segment.
   
• Providers of dialysis services are considering more complex methods of diagnosis by shifting their focus towards patients by developing their personal treatment schemes with adjustments to their workload and offering counseling for chronic dialysis patients. This should increase patient satisfaction and compliance with treatment. These factors will lead to an increase in market growth for this segment.
   

 

Based on end use, the dialysis market is segmented into in-center dialysis, and home dialysis. The in-center dialysis segment dominated the market in 2024 and is anticipated to reach USD 114.9 billion by the end of the forecast period.
 

• Patients suffering from severe complications or comorbidities tend to prefer in-center dialysis due to its availability. In-center dialysis provides patients with trained nephrologists, dialysis technicians, and nurses who assist them throughout the process with a high level of care.
   
• The safety and reliability standards that patients expect are usually met at dialysis centers. These centers use advanced hemodialysis machines and biocompatible dialyzers for emergency treatments. Other facilities also ensure high-quality care for patients.
   
• Compared to in-home therapy, in-center dialysis services tend to be more accessible and affordable due to government programs and private insurance companies partially covering the costs. For example, a lot of patients diagnosed with end-stage renal disease in the USA choose Medicare as it covers the majority, if not all, of the cost of in-center dialysis treatment.
   
• In addition, patients who are recently diagnosed and undergoing other therapies or medications often choose in-center services. The reason being that they often need guidance and assistance while they adjust to their new environment. These services are also critical to patients deemed as high risk, who depend on doctors for help during medical complications.
   
• Moreover, large companies like Fresenius Medical Care and DaVita Inc. are increasing the number of dialysis centers they operate worldwide. This expansion ensures that more patients have access to in-center services, especially in poorly served areas. This growth improves patient satisfaction and compliance with treatment, which drives market growth for this segment.
   

 In

North America region, the U.S. dialysis market accounted for USD 29.7 billion market revenue in 2024 and is anticipated to grow at a CAGR of 6% between the 2025 to 2034 period.
 

• The U.S. healthcare system has advanced technology integrated into the medical industry, positively with the existence of specific dialysis facilities and equipment. Remote patient monitoring coupled with routine dialysis clinics alongside home dialysis equipment significantly increases access to treatment. The system is further boosted by major players like Fresenius Medical Care and DaVita Inc.
   
• Moreover, the provision of dialysis services in the country is supported by government initiatives like Medicare and Medicaid. Medicare covers a substantial portion of dialysis costs for patients suffering from ESRD. This reimbursement framework provides financial security for the dialysis service providers and makes it easier for patients to avail these services.
   
• The dialysis services industry in the country is led by companies such as Fresenius Medical Care, and DaVita Inc. These firms increase competition by investing into research and development, increasing the number of dialysis centers, and developing new technologies. They also help expand the availability of dialysis services across the country.
   
• In addition, the rising cost of healthcare in the U.S. has led to more spending on dialysis clinics, modern devices, and research for new treatment options such as artificial kidneys. This increased funding supports the U.S. market and improves care for patients with CKD and ESRD, driving market growth.
   

In Europe region, Germany dialysis market is projected to grow remarkably in the coming years.
 

• Germany is investing its new technologies like high-flux dialyzers, online hemodiafiltration, and portable dialysis machines. These innovations assist in improving the quality of treatment, minimizing the risks, and increasing the patient's comfort. Thus, more patients are choosing dialysis services. Several local and international businesses have been active in supporting this trend.
   
• Also, campaigns and actions by different nephrology associations in Germany have increased awareness about kidney issues and the need for prompt action. For patients suffering from chronic kidney disease, early diagnosis permits better treatment and timely initiation of dialysis. These campaigns aim to educate the public and help reduce the rate of kidney diseases.
   
• Besides, the country is showing greater awareness and commitment to sustainable healthcare practice in dialysis services. The combination of saving water and electricity in dialysis centers, along with the development of green medical products, assist the country in achieving its sustainability objectives. These campaigns make dialysis services more appealing and stimulate industry growth.
   

Japan holds a dominant position in the Asia Pacific dialysis market.
 

• In 2023, Japan Statistics Bureau estimated that, 29.1% of the population was aged 65 or more. This number puts the country at one of the highest proportions of elderly people in the world. As the elderly population increases, the number of people suffering from chronic kidney disease (CKD) and end-stage kidney disease (ESRD) will also rise. This will lead to a higher demand for dialysis services.
   
• Moreover, according to the report of the Ministry of Health, Labour and Welfare published in 2022, there are almost 13.8 million citizens of Japan have been diagnosed with diabetes. Diabetes has extensive negative implications on  kidney health. The hypertension, which is even worse, affects nearly 43% of adults as per the census survey of 2021. These factors together, further ensure a growth in number of dialysis patients.
   
• Additionally, with the implementation of universal healthcare system in Japan, dialysis patients are ensured treatment from any hospital setting. With the introduction of National Health Insurance (NHI) scheme, the government covers 90% of the treatment cost, which improves patients willingness to seek treatment. The scheme also covers both in-center and home dialysis treatments, making the process easier for patients.
   
• Japan has one of the highest ratios of dialysis clinics to its population in the world. This ensures that patients have easy access to care. These clinics are equipped with modern dialysis machines and staffed by highly trained professionals. The strong resource network reduces travel distances for patients and increases the use of in-center dialysis treatments. Marketing campaigns also make dialysis services more appealing, which helps the industry grow further.
   

Dialysis Market Share

The market is highly competitive and is dominated by top key players like Fresenius Medical Care, DaVita Inc., B. Braun, and others, which command the largest market share of 60%. These companies have broad networks of dialysis centers along with use of advanced technology. They excel because of their size, technological advancements, and the range of services they provide. Other new and established players also increase competition by developing and marketing different dialysis services and technologies. The continuous development of dialysis equipment, an increase in the number of treatment facilities, and strategic alliances to improve service quality and operational effectiveness creates competition in the market.
 

Dialysis Market Companies

Prominent players operating in the dialysis industry include:

• angiodynamics
• Asahi KASEI
• B. Braun
• Baxter
• Becton, Dickinson and Company
• DaVita
• Dialife
• Fresenius
• JMS
• Medtronic
• NIKKISO
• NIPRO
• Rogosin Institute
• SATELLITE HEALTHCARE
• SB-KAWASUMI
• Teleflex
• TORAY
• U.S. RENAL CARE

• Fresenius Medical Care is the world’s leading provider of dialysis services and the largest manufacturer of hemodialysis machines, dialysis fluids, and patient-specific care systems. Its product offering for dialysis care is supported by a strong international presence, which guarantees optimal treatment results for patients on dialysis.
   
• Baxter is a leading provider of technologically sophisticated peritoneal and hemodialysis solutions with a focus on the improvement of lives of patients with chronic kidney disease. The company’s position as a major player in the dialysis field is also enhanced with its devotion in R&D and collaboration with healthcare professionals.
   

Dialysis Industry News

• In February 2024, Fresenius Medical Care announced that it received a 510(k) clearance from the U.S. Food and Drug Administration for the company's 5008X Hemodialysis System. The goal was to set a new standard for managing patients with kidney disorders in the United States. Their mission focuses on providing life-changing innovations and developing therapies for elderly patients with kidney problems.
   
• In April 2023, Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions. Mozarc Medical focuses on creating innovative kidney health technologies to improve the patient experience and increase access to care worldwide.
   

The dialysis market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hemodialysis
• Peritoneal dialysis

Market, By Product and Services

• Services
  • Chronic dialysis
  • Acute dialysis 
• Consumables
  • Dialyzers
  • Catheters
  • Access products
  • Concentrates
  • Other consumables
• Equipment
  • Dialysis machines
  • Water treatment systems
  • Other equipment

Market, By End Use

• In-center dialysis
• Home dialysis

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE